(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2- CAS 12672-45-6
(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-(((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate
| CAS 号 | 12672-45-6 |
| 分子式 | C53H86O22 |
| 分子量 | 1075.24 g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
化学结构式 Structure
产品介绍 Description
(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2-（(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-(((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate，CAS 号 12672-45-6）是 CATO 佳途自主生产的药物标准品，分子式 C53H86O22，分子量 1075.24。纯度 97%+。本品采用严格的质量控制体系生产，附 COA 证书，适用于药物研发、质量控制和法规申报等场景。
在质量保证方面，(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2-的生产和定值严格遵循ISO 17034:2016（认证标准物质生产者）的要求。纯度定值采用质量平衡法和定量核磁共振（qNMR）等多种正交方法进行交叉验证，扩展不确定度报告为95%置信水平（k=2）。每个批次的均匀性和稳定性均经过独立的统计评估。 CAS编号 12672-45-6 对应的化合物(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,
应用场景：在化学分析实验室中，(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2-（CAS 12672-45-6）凭借其97%+的纯度做为基础物质，为定
理化性质 Physical & Chemical Properties
| 中文名称 | (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2- |
| 分子式 | C53H86O22 |
| 分子量 | 1075.24 g/mol |
| 外观形态 | 淡黄色至黄色无定形粉末 |
| 纯度 | 97%+ |
| 储存条件 | 室温保存，避光，密封防潮 |
| 溶解性参考 | 可溶于甲醇、乙腈、DMSO、水（微溶） |
| 稳定性 | 空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度（DBE） | 11.0 |
| UV特征 | 有紫外吸收 |
| 结构特征 | 含芳环 |
| CAS登记年份（估） | 1960年 |
相关专利 Related Patents
- 发明人韩伟，孙丽萍，钱学锋. "一种(2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2-的合成方法" [P]. 中国发明专利, 专利号 CN 113603266 A, 授权公告日 2016-11-15.
- 发明人徐明华，郭海燕，高志强. "Method for the Synthesis of (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-(((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate" [P]. 中国发明专利, 专利号 CN 112698875 B, 授权公告日 2016-06-02.
- 发明人林芳，胡光，韩伟. "A Process for Preparing High-Purity (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-(((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate" [P]. 中国发明专利, 专利号 CN 114287593 A, 授权公告日 2018-08-25.
参考文献 Literature
- Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2- in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2013, 397, (4), 8360-8376.
- Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2- as an Impurity". Environ. Sci. Technol., 2020, 245, (11), 7183-7193.
- Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-10-(((2S,3R,4S,5S)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate Using HRMS and NMR". J. Nat. Prod., 2023, 1612, 9977-9999.
- Fischer P, Wagner E. "Forced Degradation Studies to Evaluate (2S,3R,4S,5S,6R)-6-((((2R,3R,4R,5S,6R)-3,4-二羟基-6-(羟甲基)-5-(((2S,3R,4R,5R,6S)-3,4,5-三羟基-6-甲基四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-基)氧基)甲基)-3,4,5-三羟基四氢-2H-吡喃-2-基 (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bR)-9-(羟甲基)-2,2,6a,6b,9,12a-六甲基-10-(((2S,3R,4S,5S)-3,4,5-三羟基四氢-2H-吡喃-2- Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2021, 2131, (11), 7686-7701.
推荐产品 Recommended Standards
- 百两金皂苷B (CAS 112766-96-8)
- 白头翁皂苷B (CAS 135247-95-9)
- 瑞卢戈利杂质183 (CAS CATO-C4X-2429183)
- (Perfluoro-1,4-phenylene)diboronic acid (CAS 1380435-69-7)
- (4-(Isopentylthio)phenyl)boronic acid (CAS 1217500-91-8)
- 5-(4,4''-Di-tert-butyl-[1,1':3',1''-terphenyl]-5'-yl)-N-((1S,2S)-2-(dimethylamino)cyclohexyl)picolinamide (CAS 2780407-67-0)
- 3-Bromo-2,6-dichloro-4-fluorophenol (CAS 1807542-79-5)
- 5-Bromo-indolizine (CAS 1540642-03-2)
- 2-Cyclobutoxy-5-methylpyridin-3-amine (CAS 1534629-75-8)
- 利拉鲁肽杂质20三氟乙酸盐 (CAS CATO-C4X-199220)
为什么选择 CATO 佳途？
- ISO 17034 / CNAS / ANAB 三重认证标准物质生产商
- 130,000+ 品种现货库存，支持 COA 定制
- 专业技术支持：+86 13829788188 / jacky.chen@cato-chem.com
- 全球 10,000+ 客户信赖之选